Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

XLV Diagnostics (Canada) | Researchclopedia

Back to institutions

XLV Diagnostics (Canada)

Thunder Bay, Ontariocompany

16

Works

1,437

Citations

9

h-index

Top Research Topics

Psoriasis: Treatment and Pathogenesis Dermatology and Skin Diseases Asthma and respiratory diseases

Top Researchers

Darryl Toth Probity Medical Research

40 works3,151 citationsh-index: 16

Recent Research

« Super-réponse » après traitement par delgocitinib 20 mg/g en crème dans un sous-groupe de patients atteints d’eczéma chronique des mains modéré à sévère

C. Bernier,April W. Armstrong,et al.

20250 citations

Spondyloarthritis Studies and Treatments

Nail Diseases and Treatments

Rheumatoid Arthritis Research and Therapies

Allergic Rhinitis and Sensitization

Contact Dermatitis and Allergies

Fungal Biology and Applications

Digital Radiography and Breast Imaging

CAR-T cell therapy research

Cytokine Signaling Pathways and Interactions

Vlad Sukhovatkin XLV Diagnostics (Canada)

35 works1,781 citationsh-index: 16

32 works1,616 citationsh-index: 19

D. Toth University of Pecs

13 works1,026 citationsh-index: 5

Dénes Tóth Probity Medical Research

40 works471 citationsh-index: 13

Sorin Marcovici XLV Diagnostics (Canada)

4 works127 citationsh-index: 2

Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents

Robert Bissonnette,Jennifer Soung,et al.

202510 citations

An illustrative case of hypopigmented mycosis fungoides

Karen Michael,Annie Langley

20251 citations

Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents

Yan Zhao,Melinda Gooderham,et al.

202514 citations

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis

Matthew Zirwas,Zoe Draelos,et al.

202333 citations

Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate‐to‐severe psoriasis through 5 years of treatment (<scp>SCULPTURE</scp> Extension Study)

Robert Bissonnette,Thomas A. Luger,et al.

2018187 citations